CM&R Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Medicine & Research
Volume 4, Number 1 : 79 -84
doi:
© 2006 Marshfield Clinic
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bozbas, H.
Right arrow Articles by Muderrisoglu, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bozbas, H.
Right arrow Articles by Muderrisoglu, H.

Review

Cardiac Enzymes, Renal Failure and Renal Transplantation

Huseyin Bozbas, MD, Aylin Yildirir, MD, FESC and Haldun Muderrisoglu, MD, FESC

Huseyin Bozbas, MD, Department of Cardiology, Baskent University Hospital, F. Cakmak Cad. 10.sok, Bahcelievler 06490 Ankara, Turkey
Aylin Yildirir, MD, FESC, Department of Cardiology, Baskent University Hospital, F. Cakmak Cad. 10.sok, Bahcelievler 06490 Ankara, Turkey
Haldun Muderrisoglu, MD, FESC, Department of Cardiology, Baskent University Hospital, F. Cakmak Cad. 10.sok, Bahcelievler 06490 Ankara, Turkey

Reprint Requests: Huseyin Bozbas, MD, Department of Cardiology, Baskent University Hospital, F. Cakmak Cad. 10.sok, Bahcelievler 06490 Ankara, Turkey. Tel.: 90-532-748-0151; Fax: 90-312-223-7333; Email: mdhbozbas{at}yahoo.com

Diagnostic accuracy of the currently available serum markers of cardiac injury, such as myoglobin, creatine kinase and its myocardial isoform, are altered in patients with renal failure. It is shown that cardiac troponins have decreased diagnostic sensitivity and specificity in patients receiving renal replacement therapy. Data regarding serum levels of these cardiac biomarkers, especially those of the cardiac troponins, in patients with a transplanted kidney are limited. Current data show that levels of cardiac troponin I are unaltered in patients who have undergone renal transplantation, while levels of cardiac troponin T may be elevated.We believe that cardiac troponin I should be the biomarker of choice for diagnosis of myocardial injury in these patients. However, further trials are required for conclusive results.

Key Words: Cardiac enzymes • Cardiac troponins • Renal failure • Renal transplantation






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by Marshfield Clinic.